FAMOTIDINE

Product NDC: 67877-843
11-digit product format: 678770843
Labeler code: 67877
Product ID: 67877-843_ea50552f-f9b9-467f-a925-62ff027df607
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: FAMOTIDINE
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Ascend Laboratories, LLC
Application: ANDA215630
Marketing category: ANDA
Marketing start: 2022-07-08
Substance: FAMOTIDINE
Active strength: 40 mg/1
Pharmacologic classes: Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	67877-843		D	Discontinued by firm	2026-08-03
excluded package	package	67877-843	67877-843-01	D	Discontinued by firm	2026-08-03
excluded package	package	67877-843	67877-843-05	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67877-843-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67877-843-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67877-843-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67877-843-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67877-843-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67877-843-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67877-843-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67877-843-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67877-843-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67877-843-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	67877-843-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	67877-843-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	67877-843-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	67877-843-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	67877-843-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	67877-843-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	67877-843-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	67877-843-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	67877-843-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	67877-843-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	67877-843-05	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	67877-843-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	67877-843-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	67877-843-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A215630-001	FAMOTIDINE	FAMOTIDINE	20MG	TABLET / ORAL	AB		2022-01-07
A215630-002	FAMOTIDINE	FAMOTIDINE	40MG	TABLET / ORAL	AB		2022-01-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A215630-001	AB
A215630-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 64 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`bb7c543d1eb4…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A215630-001	FAMOTIDINE	20MG	TABLET / ORAL	AB	2022-01-07	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A215630-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	2022-01-07	`1c564ffb4f44…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 64 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A215630-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215630-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215630-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215630-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A215630-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215630-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215630-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215630-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215630-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215630-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215630-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215630-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215630-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215630-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215630-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215630-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215630-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215630-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A215630-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A215630-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215630-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215630-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215630-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215630-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215630-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215630-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A215630-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A215630-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215630-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215630-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A215630-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A215630-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A215630-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A215630-002	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A215630-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A215630-002	AB	1	`bb7c543d1eb4…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215630-001	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215630-002	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A215630-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A215630-002	AB	1	`1c564ffb4f44…`

Additional Listing Data#

Finished product: Yes
Brand name base: FAMOTIDINE
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FAMOTIDINE	40 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5QZO15J2Z8	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
284245	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ea50552f-f9b9-467f-a925-62ff027df607	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae	Product name	7	20260317
1e73f975-1ce7-705e-2bcf-788b1b5e24ba	Product name	5	20251124
cf645750-2e70-f6e1-c05a-a52847def5dd	Product name	9	20250312
4fdc761c-585e-054b-8ebe-86130a26e4c1	Product name	2	20221205
fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
67877-843-01	FAMOTIDINE	100 in 1 BOTTLE	TABLET, FILM COATED	100		1
67877-843-05	FAMOTIDINE	500 in 1 BOTTLE	TABLET, FILM COATED	500		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67877-843-01	EA - Each	67877-843	2664fc51-a8fe-43a5-a600-3751d5c725fc	1	2022-08-04
67877-843-05	EA - Each	67877-843	198cfe40-9dd7-4610-a170-f5046f3089bb	1	2022-08-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67877-843	FAMOTIDINE TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	1	Current NDC, Legacy NDC, 2 package rows	20230826_ea50552f-f9b9-467f-a925-62ff027df607.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 22 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FAMOTIDINE	FAMOTIDINE	PD-Rx Pharmaceuticals, Inc.	a0f38398-4d34-4ecc-8a6a-37732adaaad3	2026-07-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	HAWAII REPACK, INC.	eec89230-47fc-4139-a370-b4f9e225e8c0	2026-07-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	REMEDYREPACK INC.	e59a2c97-19c7-485c-bb1b-272ddb9ae053	2026-06-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	A-S Medication Solutions	e53928f3-5181-490b-acfb-be8d4cea60a9	2026-05-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	A-S Medication Solutions	05b47b1d-f7f3-4dae-9b22-d43d2a7cfaef	2026-05-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	ST. MARY'S MEDICAL PARK PHARMACY	febe39b1-9212-a281-e053-6394a90a1a9f	2026-05-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	Preferred Pharmaceuticals Inc.	b445a613-eaa8-45e8-be1f-5848bfd1dd36	2026-04-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	Preferred Pharmaceuticals Inc.	dbf94314-3a34-4f03-80b1-296559b7d6a5	2026-04-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	REMEDYREPACK INC.	3ab235f4-da59-4a92-ad6b-c76cf3ecd985	2026-04-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	REMEDYREPACK INC.	9c5dce17-1865-4aa6-89f6-24dd55b5f06c	2026-01-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	A-S Medication Solutions	74a69baa-a7c5-4e67-8db6-2ec39ab6cfe5	2025-12-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	Bryant Ranch Prepack	7cef62ab-1740-4d0f-b6ea-fda783e1c197	2025-10-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	A-S Medication Solutions	3c32f8e2-f54a-422d-9c25-68692ea09001	2025-10-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	PD-Rx Pharmaceuticals, Inc.	a3b50576-cd40-4f7e-9506-bd0a61988424	2025-10-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	Ascend Laboratories, LLC	be69d9f9-f4ad-4cfe-bab2-e07186b25c1e	2025-08-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	Bryant Ranch Prepack	a24e8f45-6ace-4a81-8005-c23a55dadd9a	2025-03-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	NuCare Pharmceuticals,Inc.	fc603d56-6828-8c5e-e053-6394a90a35bd	2025-02-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	Bryant Ranch Prepack	077bb160-e616-4863-bdde-989140f99e1c	2024-08-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	NuCare Pharmaceuticals,Inc.	fd271deb-c748-bf26-e053-6294a90a11aa	2024-06-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630
FAMOTIDINE	FAMOTIDINE	Asclemed USA, Inc.	69bd5340-298b-46ca-83c7-0b5ef233f9c5	2024-04-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215630 application number: ANDA215630

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5QZO15J2Z8	FAMOTIDINE	76824-35-6	FAMOTIDINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
284245	famotidine 40 MG Oral Tablet	PSN	077bb160-e616-4863-bdde-989140f99e1c	102
284245	famotidine 40 MG Oral Tablet	SCD	077bb160-e616-4863-bdde-989140f99e1c	102
284245	famotidine 40 MG Oral Tablet	PSN	a3b50576-cd40-4f7e-9506-bd0a61988424	4
284245	famotidine 40 MG Oral Tablet	PSN	dbf94314-3a34-4f03-80b1-296559b7d6a5	4
284245	famotidine 40 MG Oral Tablet	SCD	a3b50576-cd40-4f7e-9506-bd0a61988424	4
284245	famotidine 40 MG Oral Tablet	SCD	dbf94314-3a34-4f03-80b1-296559b7d6a5	4
284245	famotidine 40 MG Oral Tablet	PSN	fc603d56-6828-8c5e-e053-6394a90a35bd	3
284245	famotidine 40 MG Oral Tablet	SCD	fc603d56-6828-8c5e-e053-6394a90a35bd	3
284245	famotidine 40 MG Oral Tablet	PSN	febe39b1-9212-a281-e053-6394a90a1a9f	2
284245	famotidine 40 MG Oral Tablet	SCD	febe39b1-9212-a281-e053-6394a90a1a9f	2
284245	famotidine 40 MG Oral Tablet	PSN	ea50552f-f9b9-467f-a925-62ff027df607	1
284245	famotidine 40 MG Oral Tablet	SCD	ea50552f-f9b9-467f-a925-62ff027df607	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
67877-843-01	67877084301	100 TABLET, FILM COATED in 1 BOTTLE (67877-843-01)	2022-07-08	0000-00-00	No	No	Current
67877-843-05	67877084305	500 TABLET, FILM COATED in 1 BOTTLE (67877-843-05)	2022-07-08	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FAMOTIDINE	ST. MARY'S MEDICAL PARK PHARMACY	2026-05-01	HUMAN PRESCRIPTION DRUG LABEL	2
FAMOTIDINE	Preferred Pharmaceuticals Inc.	2026-04-15	HUMAN PRESCRIPTION DRUG LABEL	4
FAMOTIDINE	PD-Rx Pharmaceuticals, Inc.	2025-10-09	HUMAN PRESCRIPTION DRUG LABEL	4
FAMOTIDINE	NuCare Pharmceuticals,Inc. \| NuCare Pharmaceuticals,Inc.	2025-02-05	HUMAN PRESCRIPTION DRUG LABEL	3
FAMOTIDINE	REMEDYREPACK INC.	2024-10-16	HUMAN PRESCRIPTION DRUG LABEL	5
FAMOTIDINE	Bryant Ranch Prepack	2024-08-23	HUMAN PRESCRIPTION DRUG LABEL	102
FAMOTIDINE	Ascend Laboratories, LLC \| VKT Pharma Private Limited	2023-08-25	Human Prescription Drug Label	1